Marc Owen - Smith Nephew Non-Executive Director

<div class='circular--portrait' style='background:#FCD202;color: white;font-size:3em;padding-top: 40px;;'>SNN</div>
SNNUF -- USA Stock  

USD 24.30  0.00  0.00%

Mr. Marc E. Owen is NonExecutive Independent Director of the Company., effective October 1, 2017. He is a Member of the Audit Committee in October 2017 and Member of the Compliance Culture Committee in March 2018. He will be appointed chair of the Compliance Culture Committee in April 2019. Career and experience Marc graduated from Oxford University with a BA and BCL in Law. In 1984 he was called to the Bar, following four years at Corporationrations Christi College Cambridge as a fellow and director of studies in law. He decided upon a corporate career and undertook an MBA at Stanford University. Marc commenced his healthcare and technology career at McKinsey Company where he progressed to senior partner and eventually a founding partner of McKinseys Business Technology Office. In September 2001, Marc joined McKesson Corporationrationration and served as Executive Vice President and member of the Executive Committee. He delivered strategic objectives and led over 40 acquisitions and divestments over a 10year period. In late 2011 he headed Mckesson Speciality Health, which operates over 130 cancer centres across the US and provides services including market intelligence, supply chain services, patient access to therapy, provider and patient engagement and clinical trial support. His final executive role came in 2014 where he was appointed Chair of the European Management Board at Celesio AG. He retired in March 2017 once he had improved operations, set the strategy and recruited his successor. Skills and competencies Marc is a proven leader with an astute, strategic vision, capable of building significant international healthcare businesses. He has strong commercial healthcare expertise which the Board values deeply and makes him ideally placed to Chair the Compliance Culture Committee.
Age: 59  Director Since 2017  MBA    
44 19 2347 7100  http://www.smith-nephew.com

Management Efficiency

The company has return on total asset (ROA) of 7.62 % which means that it generated profit of $7.62 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 14.55 % meaning that it generated $14.55 on every $100 dollars invested by stockholders.
The company has accumulated 2.18 B in total debt with debt to equity ratio (D/E) of 44.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Smith Nephew Plc has Current Ratio of 1.96 which is within standard range for the sector.

Company Summary

Smith Nephew plc develops, manufactures, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 16000 people.Smith Nephew Plc O [SNNUF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Smith Nephew Plc Leadership Team

Namal Nawana, CEO, Executive DirectorView
Michael Friedman, Non-Executive Independent DirectorView
Diogo MoreiraRato, President - Europe and CanadaView
Skip Kiil, President - OrthopedicsView
Erik Engstrom, Non-Executive DirectorView
Matthew Stober, President - Global OperationsView
Marc Owen, Non-Executive DirectorView
Rodrigo Bianchi, President IRAMEAView
Brian Larcombe, Senior Independent Non-Executive DirectorView
Elga Lohler, Chief Human Resource OfficerView
Gunthorp Oie, IR Contact OfficerView
Roland Diggelmann, Non-Executive DirectorView
Helen Maye, Chief Human Resources OfficerView
Vinita Bali, Non-Executive DirectorView
Simon Fraser, President - Advanced Wound ManagementView
Massimiliano Colella, President Europe - Middle East and AfricaView
Olivier Bohuon, CEO, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee and Member of Nomination and Governance CommitteeView
Graham Baker, CFO, Executive DirectorView
Cathy ORourke, Chief Legal and Compliance OfficerView
Roberto Quarta, Non-Executive Independent Chairman of the BoardView
Cyrille Petit, Chief Corporate Development OfficerView
Julie Brown, CFO, Director and Member of Disclosures CommitteeView
Glenn Warner, President - Advanced Wound ManagementView
Robin Freestone, Non-Executive DirectorView
Virginia Bottomley, Non-Executive Independent DirectorView
Phil Cowdy, Executive Vice President of Business Development & Corporate AffairsView
Angie Risley, Non-Executive DirectorView
Mark Gladwell, President - Global OperationsView
Vasant Padmanabhan, President - Research & DevelopmentView
Michael Frazzette, President - Advanced Surgical DevicesView
Joseph Papa, Non-Executive Independent DirectorView
Ingeborg Oie, VP, Investor RelationsView
Susan Swabey, Company SecretaryView
Melissa Guerdan, Chief Quality and Regulatory Affairs OfficerView
Gordon Howe, President of Global OperationsView
John Campo, Chief Legal OfficerView
Brad Cannon, President Europe and CanadaView
Ian Barlow, Non-Executive Independent DirectorView
Catheryn ORourke, Chief Legal OfficerView

Stock Performance Indicators

Current Sentiment - SNNUF

Smith Nephew Plc Investor Sentiment

Most of Macroaxis users are at this time bullish on Smith Nephew Plc O. What is your outlook on investing in Smith Nephew Plc O? Are you bullish or bearish?
50% Bullish
50% Bearish

Currently Active Assets on Macroaxis

Purchased over 400 shares of
a day ago
Traded for 31.54
Purchased over 100 shares of
a day ago
Traded for 125.44
Purchased over 100 shares of
a day ago
Traded for 59.77
Purchased over 100 shares of
a day ago
Traded for 11.91
Purchased over 100 shares of
a day ago
Traded for 30.64
Additionally take a look at World Market Map. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.